Release Version: 2024.06.0
June 30, 2024
We are pleased to announce a new software release with multiple new features and fixes:
Follow Up Manager tool Enhancements
Stable Option Under Asymmetry Tab
Updated Localization Device Options - MOLLI® Marker
Faster Path to Remove pre-built Prior Exam macros
Additional lesion types in Biopsy Module (Asymmetry & Asymmetry with Associated Calcifications)
New Admin Reports
Updated Method of Detection tool access
Updated workflow for changing a patient’s preferred language in patient questionnaire and follow up communications.
New AI integrations with iCAD and CureMetrix®
The Follow Up Manager tool has been updated to improve and streamline the patient follow-up process.
Features include:
Ability to select multiple status options within the Steps dialog.
Additional status options have been added, including additional Lost-To-Follow-Up options to categorize reasons for patient non-compliance.
Access to Follow-up status from Admin Reports
Resolve Lost-to-Follow-Up exams directly from Follow Up Manager tool.
New Status Options:
Previously, you could only manage follow-up steps through the Follow-up Manager. To improve workflow, we've added this functionality to the Patient Viewer when accessed from the Admin Reports screen. Now, after querying for unresolved exams in Admin Reports, you can quickly go through each unresolved exam to manage communication events and set exam resolutions.
Resolve Lost-to-Follow-up Exams Directly from Follow-up Steps Dialog:
This update allows you to quickly resolve lost-to-follow-up exams directly within the Followup Manager. Previously, you had to exit the Followup Manager to resolve an exam. Now, with a single click, you can resolve a lost-to-follow-up exam, and any status selections or notes will be carried forward as part of the resolution.
Stable Option Under Asymmetry Tab Now Selectable with Additional Options
The ability to highlight the "Stable" option with the 1 view, Global, or Focal options has been integrated into DX Mammo's Asymmetry tab as a shortcut. This enhancement should make the process more efficient and user friendly by eliminating the need to open the “Change” button solely for adding the Same or Stable option.
Updated Localization Device Options - MOLLI® Marker
We’ve integrated the MOLLI® localization marker into our Biopsy and Procedures module. MOLLI® is a ferromagnetic, wire-free soft tissue localization technology that marks the location of a lesion precisely for removal during surgery.
We have added the MOLLI® localization marker to both the "Localization" device options and the biopsy marker shapes.
Faster Path to Remove pre-built Prior Exams Macros
We have simplified the process of removing “Prior Exam” dates from the clinical report. Previously, unchecking the macro checkbox triggered a dialog requiring additional steps. Now, simply unchecking the box immediately removes the Prior Exam Dates from the clinical report without any further prompts, making your workflow more efficient.
Additional Lesion Types & Post Procedure Imaging in Biopsy Module
Updated Lesion Type Options - Asymmetry and Asymmetry with Associated Calcifications
Updated Post-procedure Imaging - Tissue density within specimen
Listed under the Specimen Imaging list, there is now an option for "Tissue density within specimen". This update allows the report to indicate "Imaging shows ares of increased density that may correspond to the target lesion within specimen."
New Admin Reports
Patients With Recommended Screening MRI with Risk Indicator
This report generates a list of exams where a recommendation for Screening Breast MRI was made based on the patient's risk assessment. This report aims to streamline high-risk patient tracking and follow-up processes.
Updated Unresolved Reports
The previous "Unresolved Exams" report has been split into three separate reports.
- Show all unresolved exams
- Limit unresolved exams to the last 365 days
- Show unresolved exams greater than 365 days
When "Method of Detection" is set for a BI-RADS 4 or 5 exam, the radiologist can either accept the Ikonopedia-recommended selection or choose a different option. We now save both the Ikonopedia-recommended selection and the radiologist’s override to provide insight into the effectiveness of the automated selections.
Additionally, we have added the “Method of Detection” selection dialog to the navigation bar for easy monitoring and adjustment by the radiologist while supervising a resident.
Updated workflow for changing a patient’s preferred language in patient questionnaire and follow up communications
A new "Save as Preferred Language" button has been added to the patient questionnaire specifically for saving the patient's preferred language in the Patient Format. This ensures that the Tech and Staff formats are restricted to English, reducing the need for frequent language adjustments.
New AI integrations with iCAD and CureMetrix®
iCAD Integration
We’ve added iCAD ProFound AI to our system. ProFound AI is a deep learning-based algorithm designed for early cancer detection and developed by iCAD. This tool is used concurrently while reading mammogram images, providing radiologists with “Certainty of Finding” and “Case Scores” to help prioritize cases and make clinical decisions. When enabled in Ikonopedia, the iCAD logo will appear on the screening page, along with an indicator showing the confidence level of detecting suspicious lesions. Clicking on the icon will display a dialog with full details about the detection.
CureMetrix® cmAngio® Integration
We’ve added CureMetrix® cmAngio®, an AI-based software, to help radiologists assess a patient’s risk of coronary heart disease (CHD). cmAngio® generates a CureMetrix® Bradley Score™ by analyzing the presence and characteristics of breast arterial calcifications in mammograms. This new feature complements our existing CureMetrix® cmTriage® AI-based triage notification system, which alerts radiologists to suspicious regions of interest identified by the algorithm. When enabled, you will notice the cmAngio® icon on the Ikonopedia screening page. This will alert the radiologist to cardiovascular risk by detecting the presence of breast arterial calcification on your mammogram.